A research group from Goethe University and University Hospital Frankfurt was able to show that an inhibitor against microRNA-92a is effective in humans. The clinical study was supported by the German Center for Cardiovascular Research (DZHK). The microRNA therapy...
ACE2 is a protein on the surface of cells and serves as the entry gate for the SARS-CoV-2 coronavirus. A Frankfurt research group was able to show that ACE2 is significantly increased in tissue samples from patients with cardiovascular diseases. COVID-19 disease...
We are excited to share that our collaborative work on “Transcriptional heterogeneity of fibroblasts is a hallmark of the aging heart” from Vidal and Wagner et. al. has been publishedin JCI Insight...
